Unknown

Dataset Information

0

Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?


ABSTRACT: During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment. We evaluate the effect of coffee's active part, 1,3,7-trimethylxanthine (TMX) on patients with COVID-19. A cohort of 93 patients, with a diagnosis of COVID-19 is analyzed. TMX group and control group included, respectively, 26 and 67 patients. In the TMX group, patients had a median length of stay in hospital of 5.5 days shorter than in the control group (9.5 vs. 15 days, p < 0.05). Patients in the control group were more severe than patients in the TMX group with a significantly higher National Early Warning Score 2 (NEWS-2 score) (8 vs. 6, p = 0.002). Multiple biases prevents us from concluding to an effect of coffee on COVID-19. Despite an important social pressure during this crisis, methodology and conscientiousness are the best way to avoid hasty conclusions that can be deleterious for patients. Identifier: NCT04395742.

SUBMITTER: Belaroussi Y 

PROVIDER: S-EPMC7698499 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?

Belaroussi Yaniss Y   Roblot Paul P   Peiffer-Smadja Nathan N   Delaye Thomas T   Mathoulin-Pelissier Simone S   Lemeux Joffrey J   Le Moal Gwenaël G   Caumes Eric E   Roblot France F   Bleibtreu Alexandre A  

Journal of clinical medicine 20201117 11


<h4>Background</h4>During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment.<h4>Methods</h4>We evaluate the effect of coffee's active part, 1,3,7-trimethylxanthine (TMX) on patients with COVID-19. A cohort of 93 patients, with a diagnosis of COVID-19 is analyzed.<h4>Results</h4>TMX group and control group in  ...[more]

Similar Datasets

| S-EPMC8929331 | biostudies-literature
| S-EPMC7321032 | biostudies-literature
| S-EPMC7547293 | biostudies-literature
2020-08-11 | GSE148113 | GEO
| S-EPMC7982825 | biostudies-literature
| S-EPMC8594646 | biostudies-literature
| S-EPMC7927769 | biostudies-literature
2021-08-13 | GSE175791 | GEO
| PRJEB62576 | ENA
| PRJEB42396 | ENA